Reneo Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
May 19, 2021 06:00 ET
|
Reneo Pharmaceuticals, Inc.
SAN DIEGO, May 19, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for...
Reneo Pharmaceuticals Announces Pricing of Initial Public Offering
April 08, 2021 21:42 ET
|
Reneo Pharmaceuticals, Inc.
SAN DIEGO, April 08, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with...
REN001 Granted Fast Track Designation by FDA for Patients with Primary Mitochondrial Myopathies
March 24, 2021 08:00 ET
|
Reneo Pharmaceuticals, Inc.
SAN DIEGO, March 24, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with...
Reneo Pharmaceuticals Appoints Vineet R. Jindal as Chief Financial Officer
March 22, 2021 08:00 ET
|
Reneo Pharmaceuticals, Inc.
SAN DIEGO, March 22, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with...
Reneo Pharmaceuticals Appoints Eric Dube, Ph.D. to its Board of Directors
March 15, 2021 08:00 ET
|
Reneo Pharmaceuticals, Inc.
SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with...